BLASUBCUTANEOUSINJECTABLE
Approved
Oct 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
14
Data completeness
2/8 — Basic
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Menopur is a subcutaneous injectable containing menotropins (human menopausal gonadotropins), a purified blend of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). It is used to stimulate ovarian follicle development in women with infertility undergoing assisted reproductive technology. The drug directly replaces endogenous gonadotropins to promote folliculogenesis and prepare the ovary for oocyte retrieval.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30); team likely focused on defending market position and managing transition.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (14)
Menopur And Rekovelle Combination Study Version 2.0
Started Jul 2025
200 enrolled
IVFControlled Ovarian SimulationFertility Disorders
Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment
Started Sep 2022
0Infertility, Female
MEDAM (Menopur Retrospective Data prograM)
Started Nov 2021
11,488 enrolled
Infertility, Female
A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women
Started Nov 2021
95 enrolled
Infertility, Female
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
Started Oct 2019
405 enrolled
Infertility
Worked on MENOPUR at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.